BIOMAT Database Logo BIOMAT Database Logo

[Prostate-specific antigen in the diagnosis of prostatic carcinoma]. 1985

J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Prostate-specific antigen in prostatic carcinoma.
January 1990, Urologia internationalis,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Prostate-specific antigen in management of prostatic carcinoma.
May 1989, Urology,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate.
January 1995, Urologic oncology,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Experience with prostate-specific antigen in prostatic carcinoma.
January 1991, International urology and nephrology,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Serum prostate-specific antigen determination in prostatic carcinoma.
January 1987, The International journal of biological markers,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
[Will determination of prostate specific antigen density improve the diagnosis of prostatic carcinoma?].
September 1997, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].
August 1990, Nederlands tijdschrift voor geneeskunde,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
May 1996, Cancer,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.
August 1993, The Journal of urology,
J A Virseda, and M Morente, and M A Piris, and A M Melchor, and B Gil Pascual, and A Gómez
Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
January 1989, European urology,
Copied contents to your clipboard!